Thymoquinone Inhibition of Acquisition and Expression of Alcohol-Induced Behavioral Sensitization.

Autor: Khan MS; Basic and Applied Pharmacology Research Group, Department of Pharmacy, COMSATS Institute of Information Technology, Abbottabad, 22060, Pakistan., Gohar A; Basic and Applied Pharmacology Research Group, Department of Pharmacy, COMSATS Institute of Information Technology, Abbottabad, 22060, Pakistan., Abbas G; Basic and Applied Pharmacology Research Group, Department of Pharmacy, COMSATS Institute of Information Technology, Abbottabad, 22060, Pakistan., Mahmood W; Basic and Applied Pharmacology Research Group, Department of Pharmacy, COMSATS Institute of Information Technology, Abbottabad, 22060, Pakistan., Rauf K; Basic and Applied Pharmacology Research Group, Department of Pharmacy, COMSATS Institute of Information Technology, Abbottabad, 22060, Pakistan., Sewell RD; Cardiff School of Pharmacy and Pharmaceutical Sciences, Cardiff University, Cardiff, CF10 3NB, UK.
Jazyk: angličtina
Zdroj: Phytotherapy research : PTR [Phytother Res] 2015 Oct; Vol. 29 (10), pp. 1610-5. Date of Electronic Publication: 2015 Jul 14.
DOI: 10.1002/ptr.5409
Abstrakt: Repeated low doses of alcohol have been shown to progressively enhance locomotor activity in mice, and this phenomenon is designated as behavioral sensitization. Thymoquinone, a major active component of Nigella sativa oil has been investigated in a number of studies for its neuroprotective effects against a variety of ailments. This study was conducted to explore the therapeutic potential of thymoquinone on the acquisition and expression of alcohol-induced behavioral sensitization. Mice treated with alcohol (2.2 g/kg/day) or saline for 13 days and subsequently challenged with an acute alcohol dose (2.2 g/kg) 5 days later were orally administered acute doses of thymoquinone (10, 20 and 30 mg/kg). Thymoquinone subacute treatment with all doses throughout alcohol exposure significantly inhibited both the development and expression phases of alcohol behavioral sensitization in a dose-dependent manner. However, acute treatment with thymoquinone (30 mg/kg) only reversed the expression phase of sensitization. These findings are explained in terms of the known GABA promoting action of thymoquinone in relation to the motive circuit within the limbic component of the basal ganglia. It is concluded that thymoquinone may be a potential therapeutic option for the treatment and prevention of alcohol induced behavioral sensitization.
(Copyright © 2015 John Wiley & Sons, Ltd.)
Databáze: MEDLINE
Externí odkaz: